Health
Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants – Newswise
Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or…
Newswise — LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2…
Continue Reading
-
Noosa News23 hours agoMeasles alert issued across popular south-east attractions
-
General23 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
General20 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
Business7 hours ago1 ASX dividend stock down 43% I’d buy right now